| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Kalaris Therapeutics, Inc. (KLRS) has 2 insiders with recent SEC Form 4 filings, including 0 buys and 13 sells. KLRS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 2.22M | $10.50M | - | |
| CFO | 235.0K | $1.11M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 19, 2024 | Sinha Vikas84 | See Remarks | Sell | 3,159 | $0.76 | $2,399.26 | -0.3% | -24.6% | -85.4% | |
| Aug 19, 2024 | Brainard Diana85 | Chief Executive Officer | Sell | 3,091 | $0.76 | $2,347.61 | -0.4% | -24.6% | -85.4% | |
| Aug 5, 2024 | Miller Edward82 | General Counsel | Sell | 2,323 | $0.73 | $1,706.94 | -1.1% | +21.3% | -84.8% | |
| Aug 5, 2024 | Brainard Diana85 | Chief Executive Officer | Sell | 10,847 | $0.73 | $7,970.38 | -1.4% | +21.3% | -84.8% | |
| Aug 5, 2024 | Sinha Vikas84 | See Remarks | Sell | 5,251 | $0.73 | $3,858.43 | -0.5% | +21.3% | -84.8% | |
| Aug 5, 2024 | Hagen Brett R84 | Chief Accounting Officer | Sell | 1,692 | $0.73 | $1,243.28 | -2.3% | +21.3% | -84.8% | |
| Jul 22, 2024 | Sinha Vikas84 | See Remarks | Sell | 3,400 | $0.74 | $2,530.09 | -0.1% | +2.2% | -85.3% | |
| Jul 22, 2024 | Hagen Brett R84 | Chief Accounting Officer | Sell | 960 | $0.74 | $714.85 | -0.6% | +2.2% | -85.3% | |
| Jul 22, 2024 | Miller Edward82 | General Counsel | Sell | 1,391 | $0.74 | $1,035.14 | -0.3% | +2.2% | -85.3% | |
| Jul 19, 2024 | Brainard Diana85 | Chief Executive Officer | Sell | 9,731 | $0.75 | $7,299.22 | -1.2% | +3.8% | -86.0% |